Skip to main content
. 2023 Jun 25;201(2):215–225. doi: 10.1007/s10549-023-06999-9

Table 5.

The administration of neoadjuvant treatment by year

Characteristic 2018, N = 20a 2019, N = 144a 2020, N = 222a 2021, N = 54a 2022, N = 60a p-valueb
Neoadjuvant treatment administered 4 (20.0%) 36 (25.0%) 72 (32.4%) 25 (46.3%) 28 (46.7%) 0.004
Neoadjuvant chemotherapy administered 3 (15.0%) 33 (22.9%) 65 (29.3%) 23 (42.6%) 27 (45.0%) 0.003

an (%)

bPearson’s Chi-squared test